fosamax class action lawsuit
Bisphosphonates have been linked to rare cases of eye inflammation, medical experts say, citing various studies documenting the osteoporosis drug’s side effects. This complication may add to the growing list of side effects that patients are warned about when taking bisphosphonates, such as, Fosamax manufacturers Merck which have been involved in class action lawsuits regarding their drugs side-effects.  

The documented types of inflammation associated with bisphosphonate therapy involved cases of uveitis, which involves the middle layer of the eye; followed by episcleritis, which pertains to the sclera or white part of the eye. In both cases eye pain, blurred vision, and redness were the most common symptoms to watch out for with tearing and light sensitivity likely resulting from episcleritis.  

According to research findings, while the dangers of certain eye inflammation ailments are rare and does not prove that bisphosphonates can cause these conditions, there is still a need to inform patients taking this medication of the dangers involved. Patients are advised that if they experience any of these symptoms while on bisphosphonates to seek medical consultation immediately. 

URL References:
 
 osteoporosis.ca/multimedia/pdf/position_statements/New_Study_Confirms_that_Potential_Side_Effect_of_Bisphosphonate_Therapy_on_the_Eyes_is_Very_Rare_April_2012.pdf